, mainly from net profit in 3Q17. Key Financial Ratio Financial ratio 3Q16 2Q17 3Q17 Current ratio 0.51 0.54 0.54 Debt to Equity ratio 1.63 1.91 2.28 Interest Bearing Debt to Equity ratio 0.48 0.67 1.00
of the Company for Q2/2019 in the amount of Baht 243.9 million (Q2/2018: Baht 250.0 million) which decreased by Baht 6.1 million or decreased by 2.4 percent. The profit before finance costs and income
with a value higher than 50 percent. In addition, the disposal transaction may constitute a connected transaction if a connected person of the Company participates in the bidding offer and becomes the
change of scoring criteria effective this year despite an increase of average number of registered patients to 176,554 from 164,812 person yoy. Operation : Consolidated Profit & Loss Statement 3Q 3Q % 9
Operating Profit Margin 18.0% 19.2% Other income 115.8 109.5 6.3 5.8 Share of profit of investment in associate 2.4 2.5 (0.1) (6.8) Profit before tax expense 1,714.8 1,659.1 55.7 3.4 Profit before tax expense
to owners of the Company for Q3/2019 in the amount of Baht 402.1 million (Q3/2018: Baht 356.5 million) which increased by Baht 45.6 million or increased by 12.8 percent. The profit before finance costs
revenues when compare to the same period in 2017 was gross margin 4.73 percent and Net loss (19.95) percent of total revenues. Table 2: Provides an overview of costs and expenses and gross profit to revenue
., Ltd. (“EFORL”), at the amount not exceeding 50 MB; and resolved to approve the investment of HHC in Franchise business of WCIG for investing in esthetic clinics under trademark “Wuttisak Clinic” at the
acquisition shall enable to generate income and profit to the Company. So that the Company shall gain much more improved financial position and operating performance. 9. Source of Fund Used in Doing the
Project), with revenue from sales. - Real estate development business expected to occurred in that quarter. In addition, the company realizes profit from buying these two businesses since the purchase price